Therefore, we speculate that during prostate cancer metastasis the downregulation of miR-448 may contribute to the upregulation of SATB1, which may explain our observation that SATB1 expression was positively correlated with the bone metastasis of prostate cancer. The gene discussed is SATB1; the disease is prostate carcinoma.